Company Developments - RLX Technology has completed the sample preparation for its self-developed oral nicotine product in 2024, with plans to launch it in the European and American markets by 2026, aiming to expand the smokeless tobacco product market through more convenient usage [2] - The company has initiated the "Seeing Love: Guide Dog Partner Program," which will run from 2025 to 2026, planning to donate 4 million yuan for the training, medical care, and education of 20 guide dogs, with the first batch of 10 guide dogs delivered in 2025 [3] Business Progress - According to the Q3 2025 financial report, RLX Technology's international business revenue has reached 72%, with ongoing expansion in the Asia-Pacific and European markets through mergers and acquisitions, such as the completion of a European acquisition in May 2025, indicating a potential for further localization efforts [4] Product Development - In addition to the oral nicotine product, the company has launched nicotine oral films in the U.S. market and continues to develop heat-not-burn (HNB) and other new tobacco products to expand its global product matrix [5]

Core Viewpoint - RLX Technology plans to launch its self-developed oral nicotine product in the European and American markets in 2026, receiving positive feedback from global distributors [2]. Recent Events - The company is implementing the "Seeing Love: Guide Dog Partner Program," which will run from 2025 to 2026, with a donation of 4 million yuan for the training, medical care, and support of 20 guide dogs. The first batch of guide dogs has already been delivered and is currently in the adaptation training phase [2]. Performance and Business Situation - According to the Q3 2025 financial report, international business revenue accounts for 72% of the company's total revenue. The company aims to strengthen its position in the Asia-Pacific and European markets through localized products and retail networks [3]. Stock Performance - Over the past 7 days (as of February 12, 2026), RLX Technology's stock price has shown volatility, closing at $2.35, with a single-day decline of 3.69%. From February 9 to February 12, the stock price dropped by a cumulative 2.49%, with a price range of 4.56%. The highest price during this period was $2.46 on February 12, while the lowest was $2.35 on the same day. On February 12, the trading volume was approximately 1.906 million shares, with a trading value of about $4.588 million. The stock's performance over the past 5 days showed a decline of 0.84%, while the tobacco sector increased by 0.95%, and the Nasdaq index saw a slight increase of 0.25% [4].

Core Viewpoint - RLX Technology plans to launch its self-developed oral nicotine product in the European and American markets by 2026, receiving positive feedback from global distributors [1] Group 1: Product Development and Market Strategy - The oral nicotine product has garnered positive responses from global distributors, indicating strong market interest [1] - The company aims to strengthen its position in the Asia-Pacific and European markets through localized products and retail networks [1] Group 2: Corporate Social Responsibility - The "Seeing Love: Guide Dog Partner Program" will be implemented from 2025 to 2026, with a plan to donate 4 million yuan for the training, medical care, and education of 20 guide dogs [1] - The first batch of guide dogs has been delivered and is currently undergoing adaptation training [1] Group 3: Financial Performance - As of the third quarter of 2025, international business revenue accounted for 72% of the company's total revenue [1]

Core Viewpoint - The company RLX Technology (雾芯科技) is experiencing significant growth, with a 40% year-over-year increase in revenue for Q2, driven by its expansion into the nicotine-containing smokeless products market and recent acquisitions in Europe [3][5][6]. Group 1: Financial Performance - Q2 revenue increased from 627 million yuan to 880 million yuan (approximately 123 million USD), marking a 40% growth compared to the same period last year [3][5]. - The company's non-GAAP profit also saw a 35% year-over-year increase, reflecting strong operational performance [5]. - The gross margin improved from 25.2% in the previous year to 27.5% in Q2, while operating expenses grew only 6.3%, significantly lower than revenue growth [7]. Group 2: Market Strategy - The company is focusing on international markets, with international revenue share rising from 17% in 2023 to over 50% by Q3 of the previous year [7]. - Recent acquisitions in Europe and plans to explore markets in the Middle East and Central America are part of the company's strategy to mitigate challenges in the domestic market [6][7]. - The company is also developing oral nicotine products and exploring other smokeless tobacco products, indicating a shift towards new product lines [8]. Group 3: Regulatory Environment - The company faces challenges in the domestic market due to illegal products, which account for 80% to 90% of the market, but it has managed to achieve "considerable" growth in China despite these issues [6][7]. - The management expresses optimism about the regulatory landscape becoming clearer, which could benefit compliant companies like RLX Technology [7]. Group 4: Shareholder Returns - The company maintains a strong cash flow, holding 15.5 billion yuan in cash and short-term investments as of June 30 [8]. - RLX Technology has engaged in stock buybacks and has announced a dividend of 0.01 USD per ADS, indicating a commitment to returning value to shareholders [8].